1. Home
  2. DNLI vs REZI Comparison

DNLI vs REZI Comparison

Compare DNLI & REZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • REZI
  • Stock Information
  • Founded
  • DNLI 2013
  • REZI 2018
  • Country
  • DNLI United States
  • REZI United States
  • Employees
  • DNLI N/A
  • REZI N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • REZI Wholesale Distributors
  • Sector
  • DNLI Health Care
  • REZI Industrials
  • Exchange
  • DNLI Nasdaq
  • REZI Nasdaq
  • Market Cap
  • DNLI 3.1B
  • REZI 3.4B
  • IPO Year
  • DNLI 2017
  • REZI N/A
  • Fundamental
  • Price
  • DNLI $20.73
  • REZI $19.45
  • Analyst Decision
  • DNLI Strong Buy
  • REZI
  • Analyst Count
  • DNLI 13
  • REZI 0
  • Target Price
  • DNLI $37.91
  • REZI N/A
  • AVG Volume (30 Days)
  • DNLI 814.8K
  • REZI 730.9K
  • Earning Date
  • DNLI 03-04-2025
  • REZI 02-20-2025
  • Dividend Yield
  • DNLI N/A
  • REZI N/A
  • EPS Growth
  • DNLI N/A
  • REZI N/A
  • EPS
  • DNLI N/A
  • REZI 0.61
  • Revenue
  • DNLI N/A
  • REZI $6,761,000,000.00
  • Revenue This Year
  • DNLI N/A
  • REZI $10.14
  • Revenue Next Year
  • DNLI $289.18
  • REZI $8.87
  • P/E Ratio
  • DNLI N/A
  • REZI $35.13
  • Revenue Growth
  • DNLI 204.74
  • REZI 8.31
  • 52 Week Low
  • DNLI $14.56
  • REZI $17.43
  • 52 Week High
  • DNLI $33.33
  • REZI $28.28
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.56
  • REZI 24.40
  • Support Level
  • DNLI $21.33
  • REZI $21.12
  • Resistance Level
  • DNLI $22.81
  • REZI $21.99
  • Average True Range (ATR)
  • DNLI 1.27
  • REZI 0.63
  • MACD
  • DNLI -0.10
  • REZI -0.11
  • Stochastic Oscillator
  • DNLI 15.83
  • REZI 3.70

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions, and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

Share on Social Networks: